TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease

[1]  Shruti Sharma,et al.  Light and electron microscopic features of surgically excised left atrial appendage in rheumatic heart disease patients with atrial fibrillation and sinus rhythm. , 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[2]  Jinbao Zhang,et al.  Suxiaojiuxin Pill Enhances Atherosclerotic Plaque Stability by Modulating the MMPs/TIMPs Balance in ApoE-deficient Mice , 2014, Journal of cardiovascular pharmacology.

[3]  J. Olgin,et al.  Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1. , 2013, Cardiovascular research.

[4]  M. Rossi,et al.  Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. , 2013, Experimental and molecular pathology.

[5]  É. Marijon,et al.  Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach. , 2012, European heart journal cardiovascular Imaging.

[6]  Z. Kassiri,et al.  Tissue inhibitor of metalloproteinases (TIMPs) in heart failure , 2012, Heart Failure Reviews.

[7]  T. Baudino,et al.  Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-β pathway , 2012, Proceedings of the National Academy of Sciences.

[8]  B. Mroczko,et al.  The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer. , 2012, Folia histochemica et cytobiologica.

[9]  Trine Krogh-Madsen,et al.  Effects of Electrical and Structural Remodeling on Atrial Fibrillation Maintenance: A Simulation Study , 2012, PLoS Comput. Biol..

[10]  Jules C Hancox,et al.  Atrial Remodeling and the Substrate for Atrial Fibrillation in Rat Hearts With Elevated Afterload , 2011, Circulation. Arrhythmia and electrophysiology.

[11]  N. Frangogiannis,et al.  Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.

[12]  R. Vasan,et al.  Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort Study , 2011, PloS one.

[13]  Y. Li,et al.  Efficacy of catheter ablation and surgical CryoMaze procedure in patients with long-lasting persistent atrial fibrillation and rheumatic heart disease: a randomized trial. , 2010, European heart journal.

[14]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  T. Munzel,et al.  Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway. , 2010, International journal of cardiology.

[16]  M. Rossi,et al.  Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension. , 2010, Journal of cardiac failure.

[17]  S. Tyagi,et al.  MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure* , 2010, Archives of physiology and biochemistry.

[18]  H. Lei,et al.  TGF‐β1 Expression and Atrial Myocardium Fibrosis Increase in Atrial Fibrillation Secondary to Rheumatic Heart Disease , 2010, Clinical cardiology.

[19]  M. Lindsey,et al.  Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences. , 2010, Journal of molecular and cellular cardiology.

[20]  J. Olgin,et al.  Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.

[21]  Vera Bittner,et al.  Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. , 2002, Heart & lung : the journal of critical care.

[22]  J. Thomas,et al.  A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. , 1996, Journal of the American College of Cardiology.

[23]  J. Sternfeld.  Evidence for differential cellular adhesion as the mechanism of sorting-out of various cellular slime mold species. , 1979, Journal of embryology and experimental morphology.

[24]  E. Schleicher,et al.  Evaluation of the Bradford method for protein determination in body fluids. , 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[25]  P. M.,et al.  World Medical Association publishes the Revised Declaration of Helsinki. , 2014, The National medical journal of India.

[26]  M. Pn.  World Medical Association publishes the Revised Declaration of Helsinki. , 2014 .

[27]  Chi‐Hang Lee,et al.  Characteristics of Aortic Wall Extracellular Matrix in Patients with Acute Myocardial Infarction: Tissue Microarray Detection of Collagen I, Collagen III and Elastin Levels , 2012 .

[28]  H. Pak,et al.  High plasma concentrations of transforming growth factor-β and tissue inhibitor of metalloproteinase-1: potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[29]  Xu-ping Li,et al.  The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation. , 2008, Medical hypotheses.

[30]  M. Savage,et al.  Surface electrocardiogram in the detection of transmural myocardial ischemia during coronary artery occlusion. , 1989, The American journal of cardiology.